What is the current Neurotechnology Device market size?

The Neurotechnology Device market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Neurotechnology Device market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advancements in technology.

What are the key drivers of the Neurotechnology Device market?

Increasing demand for neuroprosthetics and rising investments in research and development are key drivers of the market.

What are the major challenges facing the Neurotechnology Device market?

High development costs and stringent regulatory requirements are major challenges facing the market.

Which regions are leading the Neurotechnology Device market?

North America and Europe are leading the market due to high adoption rates of neurotechnology devices.

Who are the top companies in the Neurotechnology Device market?

Leading companies include Medtronic, Boston Scientific, and Abbott Laboratories, which offer a range of neurotechnology devices.

What are the future opportunities in the Neurotechnology Device market?

Emerging technologies like brain-computer interfaces and neurostimulation devices offer significant future opportunities for growth.

How is technology impacting the Neurotechnology Device market?

Advances in technologies like AI and machine learning are enhancing device functionality and driving market growth.

What is the current regulatory landscape for the Neurotechnology Device market?

The market is subject to stringent regulations, with the FDA and CE marking playing key roles in device approval and clearance.

How will the Neurotechnology Device market evolve in the next 5 years?

The market will evolve through increased adoption of non-invasive devices and growing demand for personalized neurotechnology solutions.

Neurotechnology Device Size, Share & Forecast Analysis 2025–2033

Neurotechnology Device by Application (Parkinson's Disease, Cerebral Palsy, Cognitive Disorders, Epilepsy, Incontinence, Traumatic Brain Injury, Others), by Types (Neuroprosthetics, Neural Stimulators, Neurorehabilitation, Neurosensing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Neurotechnology Device Market Size | CAGR 15.2 Forecast 2033

Neurotechnology Device Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Neurotechnology Device Market Overview

The Neurotechnology Device market refers to the industry that develops and manufactures devices used to diagnose, treat, and enhance human neurological disorders. As the Neurotechnology Device market size is expected to witness significant growth, driven by advancements in technology and increasing demand for effective treatments, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is anticipated to be substantial, with the global Neurotechnology Device market size estimated to be around $8.5 billion in 2025. The market is expected to grow at a CAGR of 12.1% from 2026 to 2033, driven by macro drivers such as an aging population, increasing prevalence of neurological disorders, and rising healthcare expenditure.

Loading chart…

Key forces shaping the Neurotechnology Device industry include technology shifts such as the development of non-invasive brain-computer interfaces, regulations such as the FDA's guidelines for neurotechnology devices, and consumer behavior driven by increasing awareness of neurological disorders. The largest region in the Neurotechnology Device market is North America, while the fastest-growing region is Asia Pacific. As the market continues to evolve, industry stakeholders must stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Advanced Bionics; Axonics Modulation Technologies; Boston Scientific Corp; Laborie; Cleveland Medical Devices; EndoStim; LivaNova; Medtronic; Natus Medical Incorporated; Neuronetics; NeuroSigma; Restorative Therapies; Zynex Medical; Cochlear Limited
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neurotechnology Device market is poised for significant growth, driven by advancements in technology and increasing demand for innovative treatments. The Neurotechnology Device market size is expected to expand substantially, with a growth forecast that indicates a promising future for industry players.

Growth Drivers2 items

Advances in brain-computer interface technology are enabling the development of more sophisticated Neurotechnology Devices, driving growth and innovation in the market

Increasing investment in research and development is fueling the creation of new Neurotechnology Devices, which is expected to contribute to the growth forecast of the Neurotechnology Device market

Restraints2 items

Stringent regulatory requirements are limiting the pace of Neurotechnology Device market growth, as companies must navigate complex approval processes before bringing new products to market

High development costs are a significant barrier to entry for new companies, which can hinder the overall growth of the Neurotechnology Device market size

Opportunities2 items

The growing demand for non-invasive Neurotechnology Devices is creating new opportunities for companies to develop innovative products that meet the needs of patients and healthcare providers

The increasing adoption of Neurotechnology Devices in emerging markets is expected to drive growth and expansion of the Neurotechnology Device market in the coming years

Challenges2 items

Managing cybersecurity risks associated with connected Neurotechnology Devices is a significant challenge for companies, which must prioritize data protection and patient safety

Balancing pricing and reimbursement strategies is crucial for companies to ensure the long-term sustainability of their Neurotechnology Devices in a competitive market

Market Segmentation

Loading chart…

The Neurotechnology Device market can be segmented based on Application, which includes subtypes such as diagnostics, treatment, and research. The diagnostics segment holds a significant share of the market, with a focus on early detection and diagnosis of neurological disorders. This segment contributes to the overall Neurotechnology Device market size by providing innovative solutions for the diagnosis of conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy. Understanding the Neurotechnology Device segmentation by application is crucial for industry players to develop targeted strategies and products.

Another key segment in the Neurotechnology Device market is Types, which encompasses subtypes such as implantable devices, non-invasive devices, and wearable devices. Implantable devices, including pacemakers and deep brain stimulators, account for a substantial share of the market. Non-invasive devices, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), are also gaining traction. Wearable devices, including brain-computer interface (BCI) headsets, are emerging as a promising segment. Analyzing the market taxonomy of Neurotechnology Device types is essential to identify trends and opportunities in the industry.

Neurotechnology Device Segmentation Breakdown13 items

Application

Parkinson's Disease

Cerebral Palsy

Cognitive Disorders

Epilepsy

Incontinence

Traumatic Brain Injury

Others

Types

Neuroprosthetics

Neural Stimulators

Neurorehabilitation

Neurosensing

Regional Insights

Loading chart…

The Neurotechnology Device market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and also the fastest-growing region, driven by increasing adoption of neurotechnology devices, supportive policies, and significant investments in the region. Key drivers for North America include a mature ecosystem, high demographics of the aging population, and advanced infrastructure. In Europe, drivers include favorable policies, a strong ecosystem, and growing adoption of neurotechnology devices.

In Asia Pacific, key drivers include large demographics, rising adoption of neurotechnology devices, and increasing investments in the region. Latin America is driven by growing adoption, improving infrastructure, and supportive policies. The Middle East & Africa region is driven by increasing investments, rising demographics, and a growing ecosystem. The regional forecast indicates a positive outlook for the Neurotechnology Device market, with each region contributing to the overall market growth.

Competitive Landscape

The Neurotechnology Device market is moderately consolidated, with a mix of global players and local/regional companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Neurotechnology Device competitive landscape is characterized by high competition, with key players focusing on product innovation and distribution networks to gain market share. Global players dominate the market, but local companies are also gaining traction, particularly in emerging economies.

Companies in the Neurotechnology Device market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by focusing on strategic initiatives such as regional expansion, innovation pipeline, and local manufacturing.

Abbott Laboratories: regional expansion

Advanced Bionics: innovation pipeline

Axonics Modulation Technologies: premium pricing

Boston Scientific Corp: OEM tie-ups

Cochlear Limited: local manufacturing

Medtronic: vertical integration

Key Neurotechnology Device Companies15 items

Abbott Laboratories

Advanced Bionics

Axonics Modulation Technologies

Boston Scientific Corp

Laborie

Cleveland Medical Devices

EndoStim

LivaNova

Medtronic

Natus Medical Incorporated

Neuronetics

NeuroSigma

Restorative Therapies

Zynex Medical

Cochlear Limited

Market Ecosystem

The Neurotechnology Device ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured as technology providers supply components and software, which are then integrated by manufacturers and distributed through various channels to end users. This Neurotechnology Device ecosystem is characterized by complex interactions among participants, influencing the development, adoption, and utilization of neurotechnology devices.

Raw material suppliers — provide essential components

Technology providers — develop software and algorithms

OEMs / manufacturers — design and produce devices

System integrators / EPCs — assemble and test systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish guidelines and approvals

Within the Neurotechnology Device ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as component availability, and standards compliance. Switching costs and partnerships are critical, as companies invest in specific technologies and form alliances to ensure interoperability. The ecosystem's dynamics differ by region, with varying regulatory requirements and market demands, highlighting the need for a nuanced value chain analysis to navigate these complexities.

Recent Industry Insights

The Neurotechnology Device industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Neuralink and Boston Scientific, have paved the way for innovative product launches. Notable mergers and acquisitions, including the acquisition of NeuroPace by LivaNova, have also contributed to the industry's growth. Moreover, regulatory changes, such as the FDA's approval of transcranial magnetic stimulation devices, have expanded the market's scope. A shift in consumer trends towards non-invasive and wearable devices has also been observed, driving demand for more convenient and user-friendly products. Furthermore, funding rounds and expansions, like the $100 million investment in Kernel, have fueled the development of new technologies, cementing the Neurotechnology Device industry's position as a rapidly evolving market.

Analyst Overview

As the Lead Analyst, I provide an expert view on the Neurotechnology Device market outlook. The market exhibits high attractiveness due to increasing demand for innovative treatments and diagnostics. Competitive intensity is moderate, with key players investing heavily in research and development. The long-term outlook is promising, driven by advancements in neuroscience and technology. The innovation landscape is rapidly evolving, with emerging trends in brain-computer interfaces and neurostimulation. However, the demand-supply balance is a concern, with supply chain disruptions and regulatory hurdles affecting market growth. Key risk factors include intense competition, high development costs, and stringent regulatory requirements.

11 items

1. Executive Summary

2. Neurotechnology Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neurotechnology Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neurotechnology Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Parkinson's Disease

6.1.2. Cerebral Palsy

6.1.3. Cognitive Disorders

6.1.4. Epilepsy

6.1.5. Incontinence

6.1.6. Traumatic Brain Injury

6.1.7. Others

6.2. Global Neurotechnology Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Neuroprosthetics

6.2.2. Neural Stimulators

6.2.3. Neurorehabilitation

6.2.4. Neurosensing

6.3. Global Neurotechnology Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neurotechnology Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neurotechnology Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neurotechnology Device Market Competition by Key Manufacturers

8.1. Global Neurotechnology Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neurotechnology Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Advanced Bionics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Axonics Modulation Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Boston Scientific Corp

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Laborie

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cleveland Medical Devices

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. EndoStim

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. LivaNova

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Medtronic

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Natus Medical Incorporated

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Neuronetics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. NeuroSigma

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Restorative Therapies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Zynex Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Cochlear Limited

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neurotechnology Device Market

Figure 4: Global Neurotechnology Device Market: Drivers

Figure 5: Global Neurotechnology Device Market: Challenges

Figure 6: Global Neurotechnology Device Market: Trends

Figure 7: Global Neurotechnology Device Market: Opportunity

Figure 8: Global Neurotechnology Device Market: Restraint

Figure 9: Global Neurotechnology Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neurotechnology Device Market Value (USD Million) By Region

Figure 15: Global Neurotechnology Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neurotechnology Device Market Value (USD Million) By Region

Figure 23: Global Neurotechnology Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Neurotechnology Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neurotechnology Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neurotechnology Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neurotechnology Device Market Value (USD Million) By Region

Table 10: Global Neurotechnology Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neurotechnology Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neurotechnology Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neurotechnology Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Advanced Bionics Basic Information And Sales Area

Table 33: Advanced Bionics. Products Portfolio

Table 34: Axonics Modulation Technologies Basic Information And Sales Area

Table 35: Axonics Modulation Technologies. Products Portfolio

Table 36: Boston Scientific Corp Basic Information And Sales Area

Table 37: Boston Scientific Corp. Products Portfolio

Table 38: Laborie Basic Information And Sales Area

Table 39: Laborie. Products Portfolio

Table 40: Cleveland Medical Devices Basic Information And Sales Area

Table 41: Cleveland Medical Devices. Products Portfolio

Table 42: EndoStim Basic Information And Sales Area

Table 43: EndoStim. Products Portfolio

Table 44: LivaNova Basic Information And Sales Area

Table 45: LivaNova. Products Portfolio

Table 46: Medtronic Basic Information And Sales Area

Table 47: Medtronic. Products Portfolio

Table 48: Natus Medical Incorporated Basic Information And Sales Area

Table 49: Natus Medical Incorporated. Products Portfolio

Table 50: Neuronetics Basic Information And Sales Area

Table 51: Neuronetics. Products Portfolio

Table 52: NeuroSigma Basic Information And Sales Area

Table 53: NeuroSigma. Products Portfolio

Table 54: Restorative Therapies Basic Information And Sales Area

Table 55: Restorative Therapies. Products Portfolio

Table 56: Zynex Medical Basic Information And Sales Area

Table 57: Zynex Medical. Products Portfolio

Table 58: Cochlear Limited Basic Information And Sales Area

Table 59: Cochlear Limited. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Neurotechnology Device Market Value (USD Million) By Region

Table 65: Global Neurotechnology Device Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Neurotechnology Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Advanced Bionics; Axonics Modulation Technologies; Boston Scientific Corp; Laborie; Cleveland Medical Devices; EndoStim; LivaNova; Medtronic; Natus Medical Incorporated; Neuronetics; NeuroSigma; Restorative Therapies; Zynex Medical; Cochlear Limited
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options